We Investigated the Relationship Between Plasma FGF23 Levels and Endothelial Dysfunction in a Sizable Series of Incident Stage 3-4 CKD Patients.
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD) (NCT01135615) | Gulhane School of Medicine | 2008-01-01 |
Track We Investigated the Relationship Between Plasma FGF23 Levels and Endothelial Dysfunction in a Sizable Series of Incident Stage 3-4 CKD Patients. automatically
Every clearance here is in the API, with alerts when new ones post.